Sunshine Biopharma Inc. (SBFM) is a publicly traded Healthcare sector company. As of October 14, 2026, SBFM trades at $0.24 with a market cap of $1.17M and a P/E ratio of -0.56. SBFM moved +0.55% today. Year to date, SBFM is -98.15%; over the trailing twelve months it is -98.49%. Its 52-week range spans $0.23 to $39.00. Rallies surfaces SBFM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Sunshine Biopharma raises about $6 million in offering, with warrants for up to $14.4 million more: Sunshine Biopharma closed a public offering that raised about $6 million in gross proceeds. Its Series D warrants could generate about $14.4 million in additional gross proceeds if fully exercised for cash.
| Metric | Value |
|---|---|
| Price | $0.24 |
| Market Cap | $1.17M |
| P/E Ratio | -0.56 |
| EPS | $-1.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.00 |
| 52-Week Low | $0.23 |
| Volume | 1.49M |
| Avg Volume | 0 |
| Revenue (TTM) | $36.31M |
| Net Income | $-5.98M |
| Gross Margin | 33.76% |
SBFM analyst coverage data. Average price target: $0.00.